SVB Leerink cut Biogen Inc.BIIBprice target from $325 to $300. Biogen shares fell 0.1% to $220.44 in pre-market trading.HC Wainwright & Co. cut TG Therapeutics, Inc. price target from $75 to $70. TG ...
Source LinkSVB Leerink cut Biogen Inc.BIIBprice target from $325 to $300. Biogen shares fell 0.1% to $220.44 in pre-market trading.HC Wainwright & Co. cut TG Therapeutics, Inc. price target from $75 to $70. TG ...
Source Link
Comments